These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


134 related items for PubMed ID: 11798561

  • 1. [The role of insulin-like growth factor-I gene expression abnormality in pathogenesis of diabetic peripheral neuropathy].
    Li J, Wang C, Chen J, Li X, Feng Z, Ma H.
    Zhonghua Nei Ke Za Zhi; 2001 Feb; 40(2):93-7. PubMed ID: 11798561
    [Abstract] [Full Text] [Related]

  • 2. The role of IGF-1 gene expression abnormality in pathogenesis of diabetic peripheral neuropathy.
    Jianbo L, Chengya W, Jiawei C, Xiaolu L, Zhenqing F, Hongtai M.
    Chin Med Sci J; 2002 Dec; 17(4):204-9. PubMed ID: 12901506
    [Abstract] [Full Text] [Related]

  • 3. [Effect of xiaokeling concentration fluid on mRNA expression of insulin-like growth factor-1 in sciatic nerve of Streptozotocin-induced diabetic rats].
    Zeng JZ, Dong KL, Li GC, Li LM.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Feb; 30(1):49-52. PubMed ID: 15871187
    [Abstract] [Full Text] [Related]

  • 4. Expression of liver insulin-like growth factor 1 gene and its serum level in patients with diabetes.
    Li JB, Wang CY, Chen JW, Feng ZQ, Ma HT.
    World J Gastroenterol; 2004 Jan 15; 10(2):255-9. PubMed ID: 14716834
    [Abstract] [Full Text] [Related]

  • 5. The preventive efficacy of methylcobalamin on rat peripheral neuropathy influenced by diabetes via neural IGF-1 levels.
    Jian-bo L, Cheng-ya W, Jia-wei C, Xiao-lu L, Zhen-qing F, Hong-tai M.
    Nutr Neurosci; 2010 Apr 15; 13(2):79-86. PubMed ID: 20406575
    [Abstract] [Full Text] [Related]

  • 6. Insulin-like growth factor (IGF) gene expression is reduced in neural tissues and liver from rats with non-insulin-dependent diabetes mellitus, and IGF treatment ameliorates diabetic neuropathy.
    Zhuang HX, Wuarin L, Fei ZJ, Ishii DN.
    J Pharmacol Exp Ther; 1997 Oct 15; 283(1):366-74. PubMed ID: 9336345
    [Abstract] [Full Text] [Related]

  • 7. Early reduction in insulin-like growth factor gene expression in diabetic nerve.
    Wuarin L, Guertin DM, Ishii DN.
    Exp Neurol; 1994 Nov 15; 130(1):106-14. PubMed ID: 7821385
    [Abstract] [Full Text] [Related]

  • 8. Exercise and insulin-like growth factor 1 supplementation improve angiogenesis and angiogenic cytokines in a rat model of diabetes-induced neuropathy.
    Saboory E, Gholizadeh-Ghaleh Aziz S, Samadi M, Biabanghard A, Chodari L.
    Exp Physiol; 2020 May 15; 105(5):783-792. PubMed ID: 32053260
    [Abstract] [Full Text] [Related]

  • 9. [Effect of electroacupuncture on mRNA expression of NGF and IGF-1 in injured nerve].
    Chen XD, Gu YD, Yang Y.
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2000 Nov 15; 14(6):328-31. PubMed ID: 12516429
    [Abstract] [Full Text] [Related]

  • 10. Expression of hepatic insulin-like growth factor-I and insulin-like growth factor-binding protein-1 genes is transcriptionally regulated in streptozotocin-diabetic rats.
    Pao CI, Farmer PK, Begovic S, Goldstein S, Wu GJ, Phillips LS.
    Mol Endocrinol; 1992 Jun 15; 6(6):969-77. PubMed ID: 1379675
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Insulin-like growth factors reverse or arrest diabetic neuropathy: effects on hyperalgesia and impaired nerve regeneration in rats.
    Zhuang HX, Snyder CK, Pu SF, Ishii DN.
    Exp Neurol; 1996 Aug 15; 140(2):198-205. PubMed ID: 8690062
    [Abstract] [Full Text] [Related]

  • 13. Pituitary insulin-like growth factor-I content and gene expression in the streptozotocin-diabetic rat: evidence for tissue-specific regulation.
    Olchovsky D, Bruno JF, Gelato MC, Song J, Berelowitz M.
    Endocrinology; 1991 Feb 15; 128(2):923-8. PubMed ID: 1989870
    [Abstract] [Full Text] [Related]

  • 14. Pre- and post-translational regulation of renal insulin-like growth factor binding protein-1 in insulin-deficient diabetes.
    Kaufman CR, Catanese VM.
    J Investig Med; 1995 Apr 15; 43(2):178-86. PubMed ID: 7537614
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Neuroactive steroid treatment modulates myelin lipid profile in diabetic peripheral neuropathy.
    Mitro N, Cermenati G, Brioschi E, Abbiati F, Audano M, Giatti S, Crestani M, De Fabiani E, Azcoitia I, Garcia-Segura LM, Caruso D, Melcangi RC.
    J Steroid Biochem Mol Biol; 2014 Sep 15; 143():115-21. PubMed ID: 24607810
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.